Benzinga | Aug 6, 2021 05:56AM EDT

JP Morgan Downgrades Kala Pharmaceuticals to Neutral

JP Morgan analyst Christopher Neyor downgrades Kala Pharmaceuticals (NASDAQ:KALA) from Overweight to Neutral.